We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.37B
1-Year Est. Return
71.68%
This Fund
S&P 500
This Quarter
Est. Return
+23.86%
1 Year Est. Return
+71.68%
3 Year Est. Return
+198.05%
5 Year Est. Return
+324.32%
10 Year Est. Return
+2,686.25%
AUM
$1.37B
AUM Growth
+$61.8M
(+4.7%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-8.67%
Top 10 Holdings %
Top 10 Hldgs %
11.44%
Holding
1,623
New
447
Increased
343
Reduced
364
Closed
410
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JHG
Janus Henderson
JHG
|
+$11.4M |
| 2 |
Roku
ROKU
|
+$8.72M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$8.2M |
| 4 |
Oracle
ORCL
|
+$7.64M |
| 5 |
NUVL
Nuvalent
NUVL
|
+$7.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$25.1M |
| 2 |
Seagate
STX
|
+$20.6M |
| 3 |
CWAN
Clearwater Analytics
CWAN
|
+$14.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$12.3M |
| 5 |
ACLX
Arcellx
ACLX
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.02% |
| 2 | Healthcare | 12.44% |
| 3 | Industrials | 12.15% |
| 4 | Consumer Discretionary | 11.47% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Banco Bradesco
BBD
$37B
| $90.2K | 0.01% |
26,000
-20,000
| -43% | -$73.2K |
|
1127
SOPHiA GENETICS
SOPH
$679M
| $90K | 0.01% |
+15,596
| New | +$79.1K |
|
1128
Aspen Aerogels
ASPN
$409M
| $88.2K | 0.01% |
+13,911
| New | +$68.2K |
|
1129
Mativ Holdings
MATV
$664M
| $88.1K | 0.01% |
11,644
-18,629
| -62% | -$160K |
|
1130
CALL
Ouster
OUST
$2.45B
| $85.8K | 0.01% |
+12,000
| New | +$404K |
|
1131
Orion
OEC
$325M
| $85.6K | 0.01% |
+12,905
| New | +$92.8K |
|
1132
Amplify Energy
AMPY
$189M
| $85.3K | 0.01% |
21,421
-173
| -0.8% | -$888 |
|
1133
eGain
EGAN
$141M
| $85K | 0.01% |
+13,500
| New | +$99K |
|
1134
CALL
iShares Bitcoin Trust
IBIT
$59.7B
| $85K | 0.01% |
+45,000
| New | +$1.83M |
|
|
BIVIW
1135
BioVie Inc Warrant
BIVIW
$120K
| $84K | 0.01% |
186,621
| – | – |
|
1136
Community Health Systems
CYH
$420M
| $83.2K | 0.01% |
+24,900
| New | +$73.3K |
|
1137
N-able
NABL
$727M
| $80.7K | 0.01% |
22,000
+7,499
| +52% | +$31.2K |
|
1138
CALL
Compass Diversified
CODI
$828M
| $80.5K | 0.01% |
+35,000
| New | +$382K |
|
|
API
1139
Agora
API
$338M
| $79.8K | 0.01% |
20,001
+4,001
| +25% | +$16.1K |
|
1140
Ironwood Pharmaceuticals
IRWD
$689M
| $77.5K | 0.01% |
+18,400
| New | +$70.9K |
|
1141
Funko
FNKO
$295M
| $75.6K | 0.01% |
+12,862
| New | +$61.8K |
|
1142
Verastem
VSTM
$663M
| $75.2K | 0.01% |
19,673
-125,046
| -86% | -$605K |
|
1143
Protara Therapeutics
TARA
$214M
| $74.9K | 0.01% |
+19,613
| New | +$93.3K |
|
1144
NIO
NIO
$8.97B
| $74.2K | 0.01% |
14,665
-19,524
| -57% | -$114K |
|
1145
Thryv Holdings
THRY
$87.5M
| $73.5K | 0.01% |
18,656
-9,359
| -33% | -$33.3K |
|
|
UPB
1146
Upstream Bio Inc
UPB
$292M
| $73K | 0.01% |
+10,550
| New | +$88.4K |
|
1147
Gain Therapeutics
GANX
$75.1M
| $72.7K | 0.01% |
35,820
| – | – |
|
|
AARD
1148
Aardvark Therapeutics
AARD
$113M
| $71.6K | 0.01% |
12,426
-18,211
| -59% | -$85.1K |
|
1149
Cerus
CERS
$510M
| $71.5K | 0.01% |
+24,500
| New | +$59.4K |
|
1150
Cricut
CRCT
$1.17B
| $69.8K | 0.01% |
15,900
-13,200
| -45% | -$56.5K |
|
Similar funds
CA
MCI
WC
OCAI
AIP
FBCM
FCM
KPF
Prelude Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Prelude Capital Management held 1,623 positions worth $1.37B, up 4.7% from $1.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Prelude Capital Management withdrew a net $119M in Q2 2026, closing 410 positions and reducing 364 holdings. Its most notable exit was Clearwater Analytics, an estimated $14.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Prelude Capital Management opened a new position in Vanguard S&P 500 ETF worth $8.44M.
- Prelude Capital Management's largest Q2 2026 buy was Vanguard S&P 500 ETF: 12,295 shares worth $8.44M.
- Prelude Capital Management added most to Janus Henderson in Q2 2026, an estimated $11.4M increase.
- Prelude Capital Management's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $25.1M.
- Prelude Capital Management fully exited Clearwater Analytics in Q2 2026, selling an estimated $14.7M.
- Prelude Capital Management's ten largest holdings make up 11% of its $1.37B portfolio in Q2 2026.
- Prelude Capital Management opened 447 new positions and closed 410 in Q2 2026.
- Prelude Capital Management's portfolio value rose 4.7% quarter-over-quarter to $1.37B.
Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.